Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Determination of MIC Quality Control Ranges for the Novel Gyrase Inhibitor Zoliflodacin.

Miller AA, Traczewski MM, Huband MD, Bradford PA, Mueller JP.

J Clin Microbiol. 2019 Aug 26;57(9). pii: e00567-19. doi: 10.1128/JCM.00567-19. Print 2019 Sep.

PMID:
31315953
2.

Community-based breeding programmes are a viable solution for Ethiopian small ruminant genetic improvement but require public and private investments.

Haile A, Gizaw S, Getachew T, Mueller JP, Amer P, Rekik M, Rischkowsky B.

J Anim Breed Genet. 2019 Sep;136(5):319-328. doi: 10.1111/jbg.12401. Epub 2019 Apr 30.

PMID:
31037758
3.

Single-Dose Pharmacokinetics, Excretion, and Metabolism of Zoliflodacin, a Novel Spiropyrimidinetrione Antibiotic, in Healthy Volunteers.

O'Donnell J, Lawrence K, Vishwanathan K, Hosagrahara V, Mueller JP.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01808-18. doi: 10.1128/AAC.01808-18. Print 2019 Jan.

4.

Polarization state generation and measurement with a single metasurface.

Rubin NA, Zaidi A, Juhl M, Li RP, Mueller JPB, Devlin RC, Leósson K, Capasso F.

Opt Express. 2018 Aug 20;26(17):21455-21478. doi: 10.1364/OE.26.021455.

PMID:
30130853
5.

High-efficiency chiral meta-lens.

Groever B, Rubin NA, Mueller JPB, Devlin RC, Capasso F.

Sci Rep. 2018 May 8;8(1):7240. doi: 10.1038/s41598-018-25675-3.

6.

Arbitrary spin-to-orbital angular momentum conversion of light.

Devlin RC, Ambrosio A, Rubin NA, Mueller JPB, Capasso F.

Science. 2017 Nov 17;358(6365):896-901. doi: 10.1126/science.aao5392. Epub 2017 Nov 2.

PMID:
29097490
7.

ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii.

Durand-Réville TF, Guler S, Comita-Prevoir J, Chen B, Bifulco N, Huynh H, Lahiri S, Shapiro AB, McLeod SM, Carter NM, Moussa SH, Velez-Vega C, Olivier NB, McLaughlin R, Gao N, Thresher J, Palmer T, Andrews B, Giacobbe RA, Newman JV, Ehmann DE, de Jonge B, O'Donnell J, Mueller JP, Tommasi RA, Miller AA.

Nat Microbiol. 2017 Jun 30;2:17104. doi: 10.1038/nmicrobiol.2017.104.

PMID:
28665414
8.

Multidrug-Resistant Neisseria gonorrhoeae Isolates from Nanjing, China, Are Sensitive to Killing by a Novel DNA Gyrase Inhibitor, ETX0914 (AZD0914).

Su XH, Wang BX, Le WJ, Liu YR, Wan C, Li S, Alm RA, Mueller JP, Rice PA.

Antimicrob Agents Chemother. 2015 Oct 19;60(1):621-3. doi: 10.1128/AAC.01211-15. Print 2016 Jan.

9.

Lateral chirality-sorting optical forces.

Hayat A, Mueller JP, Capasso F.

Proc Natl Acad Sci U S A. 2015 Oct 27;112(43):13190-4. doi: 10.1073/pnas.1516704112. Epub 2015 Oct 9.

10.

Corrigendum: Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases.

Basarab GS, Kern GH, McNulty J, Mueller JP, Lawrence K, Vishwanathan K, Alm RA, Barvian K, Doig P, Galullo V, Gardner H, Gowravaram M, Huband M, Kimzey A, Morningstar M, Kutschke A, Lahiri SD, Perros M, Singh R, Schuck VJ, Tommasi R, Walkup G, Newman JV.

Sci Rep. 2015 Sep 18;5:14157. doi: 10.1038/srep14157. No abstract available.

11.

Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases.

Basarab GS, Kern GH, McNulty J, Mueller JP, Lawrence K, Vishwanathan K, Alm RA, Barvian K, Doig P, Galullo V, Gardner H, Gowravaram M, Huband M, Kimzey A, Morningstar M, Kutschke A, Lahiri SD, Perros M, Singh R, Schuck VJ, Tommasi R, Walkup G, Newman JV.

Sci Rep. 2015 Jul 14;5:11827. doi: 10.1038/srep11827. Erratum in: Sci Rep. 2015;5:14157.

12.

SAR and Structural Analysis of Siderophore-Conjugated Monocarbam Inhibitors of Pseudomonas aeruginosa PBP3.

Murphy-Benenato KE, Dangel B, Davis HE, Durand-Réville TF, Ferguson AD, Gao N, Jahić H, Mueller JP, Manyak EL, Quiroga O, Rooney M, Sha L, Sylvester M, Wu F, Zambrowski M, Zhao SX.

ACS Med Chem Lett. 2015 Mar 22;6(5):537-42. doi: 10.1021/acsmedchemlett.5b00026. eCollection 2015 May 14.

13.

Community-based livestock breeding programmes: essentials and examples.

Mueller JP, Rischkowsky B, Haile A, Philipsson J, Mwai O, Besbes B, Valle Zárate A, Tibbo M, Mirkena T, Duguma G, Sölkner J, Wurzinger M.

J Anim Breed Genet. 2015 Apr;132(2):155-68. doi: 10.1111/jbg.12136.

PMID:
25823840
14.

Characterization of the novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in Neisseria gonorrhoeae.

Alm RA, Lahiri SD, Kutschke A, Otterson LG, McLaughlin RE, Whiteaker JD, Lewis LA, Su X, Huband MD, Gardner H, Mueller JP.

Antimicrob Agents Chemother. 2015 Mar;59(3):1478-86. doi: 10.1128/AAC.04456-14. Epub 2014 Dec 22.

15.

In vitro antibacterial activity of AZD0914, a new spiropyrimidinetrione DNA gyrase/topoisomerase inhibitor with potent activity against Gram-positive, fastidious Gram-Negative, and atypical bacteria.

Huband MD, Bradford PA, Otterson LG, Basarab GS, Kutschke AC, Giacobbe RA, Patey SA, Alm RA, Johnstone MR, Potter ME, Miller PF, Mueller JP.

Antimicrob Agents Chemother. 2015 Jan;59(1):467-74. doi: 10.1128/AAC.04124-14. Epub 2014 Nov 10.

16.

Discovery and structural characterization of an allosteric inhibitor of bacterial cis-prenyltransferase.

Danley DE, Baima ET, Mansour M, Fennell KF, Chrunyk BA, Mueller JP, Liu S, Qiu X.

Protein Sci. 2015 Jan;24(1):20-6. doi: 10.1002/pro.2579. Epub 2014 Nov 6.

17.

Polarization-selective coupling to long-range surface plasmon polariton waveguides.

Mueller JP, Leosson K, Capasso F.

Nano Lett. 2014 Oct 8;14(10):5524-7. doi: 10.1021/nl501860r. Epub 2014 Sep 8.

PMID:
25153029
18.

Pyridone-conjugated monobactam antibiotics with gram-negative activity.

Brown MF, Mitton-Fry MJ, Arcari JT, Barham R, Casavant J, Gerstenberger BS, Han S, Hardink JR, Harris TM, Hoang T, Huband MD, Lall MS, Lemmon MM, Li C, Lin J, McCurdy SP, McElroy E, McPherson C, Marr ES, Mueller JP, Mullins L, Nikitenko AA, Noe MC, Penzien J, Plummer MS, Schuff BP, Shanmugasundaram V, Starr JT, Sun J, Tomaras A, Young JA, Zaniewski RP.

J Med Chem. 2013 Jul 11;56(13):5541-52. doi: 10.1021/jm400560z. Epub 2013 Jun 27.

PMID:
23755848
19.

Polarization-controlled tunable directional coupling of surface plasmon polaritons.

Lin J, Mueller JP, Wang Q, Yuan G, Antoniou N, Yuan XC, Capasso F.

Science. 2013 Apr 19;340(6130):331-4. doi: 10.1126/science.1233746.

20.

Clinically relevant Gram-negative resistance mechanisms have no effect on the efficacy of MC-1, a novel siderophore-conjugated monocarbam.

McPherson CJ, Aschenbrenner LM, Lacey BM, Fahnoe KC, Lemmon MM, Finegan SM, Tadakamalla B, O'Donnell JP, Mueller JP, Tomaras AP.

Antimicrob Agents Chemother. 2012 Dec;56(12):6334-42. doi: 10.1128/AAC.01345-12. Epub 2012 Oct 1.

21.

Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infections.

Mitton-Fry MJ, Arcari JT, Brown MF, Casavant JM, Finegan SM, Flanagan ME, Gao H, George DM, Gerstenberger BS, Han S, Hardink JR, Harris TM, Hoang T, Huband MD, Irvine R, Lall MS, Megan Lemmon M, Li C, Lin J, McCurdy SP, Mueller JP, Mullins L, Niosi M, Noe MC, Pattavina D, Penzien J, Plummer MS, Risley H, Schuff BP, Shanmugasundaram V, Starr JT, Sun J, Winton J, Young JA.

Bioorg Med Chem Lett. 2012 Sep 15;22(18):5989-94. doi: 10.1016/j.bmcl.2012.07.005. Epub 2012 Jul 20. Erratum in: Bioorg Med Chem Lett. 2015 Sep 15;25(18):4029.

PMID:
22892121
22.

Preparation, gram-negative antibacterial activity, and hydrolytic stability of novel siderophore-conjugated monocarbam diols.

Flanagan ME, Brickner SJ, Lall M, Casavant J, Deschenes L, Finegan SM, George DM, Granskog K, Hardink JR, Huband MD, Hoang T, Lamb L, Marra A, Mitton-Fry M, Mueller JP, Mullins LM, Noe MC, O'Donnell JP, Pattavina D, Penzien JB, Schuff BP, Sun J, Whipple DA, Young J, Gootz TD.

ACS Med Chem Lett. 2011 Mar 2;2(5):385-90. doi: 10.1021/ml200012f. eCollection 2011 May 12.

23.

The 5-lipoxygenase pathway regulates vasculogenesis in differentiating mouse embryonic stem cells.

Finkensieper A, Kieser S, Bekhite MM, Richter M, Mueller JP, Graebner R, Figulla HR, Sauer H, Wartenberg M.

Cardiovasc Res. 2010 Apr 1;86(1):37-44. doi: 10.1093/cvr/cvp385. Epub 2009 Dec 4.

PMID:
19965960
24.

Key pathogens and emerging therapies in infectious diseases.

Miller PF, Mueller JP.

Curr Opin Pharmacol. 2009 Oct;9(5):535-6. doi: 10.1016/j.coph.2009.09.001. Epub 2009 Sep 18. No abstract available.

PMID:
19766536
25.

Rational drug design via intrinsically disordered protein.

Cheng Y, LeGall T, Oldfield CJ, Mueller JP, Van YY, Romero P, Cortese MS, Uversky VN, Dunker AK.

Trends Biotechnol. 2006 Oct;24(10):435-42. Epub 2006 Jul 28.

PMID:
16876893
26.

Fecal contamination of agricultural soils before and after hurricane-associated flooding in North Carolina.

Casteel MJ, Sobsey MD, Mueller JP.

J Environ Sci Health A Tox Hazard Subst Environ Eng. 2006;41(2):173-84.

PMID:
16423723
27.

The CentriMag: a new optimized centrifugal blood pump with levitating impeller.

Mueller JP, Kuenzli A, Reuthebuch O, Dasse K, Kent S, Zuend G, Turina MI, Lachat ML.

Heart Surg Forum. 2004;7(5):E477-80.

PMID:
15802261
28.

CJ-21,058, a new SecA inhibitor isolated from a fungus.

Sugie Y, Inagaki S, Kato Y, Nishida H, Pang CH, Saito T, Sakemi S, Dib-Hajj F, Mueller JP, Sutcliffe J, Kojima Y.

J Antibiot (Tokyo). 2002 Jan;55(1):25-9.

29.

Effective antigen-specific immunotherapy in the marmoset model of multiple sclerosis.

McFarland HI, Lobito AA, Johnson MM, Palardy GR, Yee CS, Jordan EK, Frank JA, Tresser N, Genain CP, Mueller JP, Matis LA, Lenardo MJ.

J Immunol. 2001 Feb 1;166(3):2116-21.

30.

Development of a scintillation proximity assay for beta-ketoacyl-acyl carrier protein synthase III.

He X, Mueller JP, Reynolds KA.

Anal Biochem. 2000 Jun 15;282(1):107-14.

PMID:
10860506
31.

Primary structure and functional characterization of a soluble, alternatively spliced form of B7-1.

Faas SJ, Giannoni MA, Mickle AP, Kiesecker CL, Reed DJ, Wu D, Fodor WL, Mueller JP, Matis LA, Rother RP.

J Immunol. 2000 Jun 15;164(12):6340-8.

32.

Adhesion of acidic lipid vesicles by 21.5 kDa (recombinant) and 18.5 kDa isoforms of myelin basic protein.

Boggs JM, Rangaraj G, Koshy KM, Mueller JP.

Biochim Biophys Acta. 2000 Jan 15;1463(1):81-7.

33.

Determinant spreading associated with demyelination in a nonhuman primate model of multiple sclerosis.

McFarland HI, Lobito AA, Johnson MM, Nyswaner JT, Frank JA, Palardy GR, Tresser N, Genain CP, Mueller JP, Matis LA, Lenardo MJ.

J Immunol. 1999 Feb 15;162(4):2384-90.

34.
35.

Immune tolerance mediated by recombinant proteolipid protein prevents experimental autoimmune encephalomyelitis.

Elliott EA, Cofiell R, Wilkins JA, Raine CS, Matis LA, Mueller JP.

J Neuroimmunol. 1997 Oct;79(1):1-11.

PMID:
9357441
36.

Humanized porcine VCAM-specific monoclonal antibodies with chimeric IgG2/G4 constant regions block human leukocyte binding to porcine endothelial cells.

Mueller JP, Giannoni MA, Hartman SL, Elliott EA, Squinto SP, Matis LA, Evans MJ.

Mol Immunol. 1997 Apr;34(6):441-52.

PMID:
9307060
37.

Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.

Elliott EA, McFarland HI, Nye SH, Cofiell R, Wilson TM, Wilkins JA, Squinto SP, Matis LA, Mueller JP.

J Clin Invest. 1996 Oct 1;98(7):1602-12.

38.

The psa locus is responsible for thermoinducible binding of Yersinia pseudotuberculosis to cultured cells.

Yang Y, Merriam JJ, Mueller JP, Isberg RR.

Infect Immun. 1996 Jul;64(7):2483-9.

40.
41.
42.

Porcine vascular cell adhesion molecule (VCAM) mediates endothelial cell adhesion to human T cells. Development of blocking antibodies specific for porcine VCAM.

Mueller JP, Evans MJ, Cofiell R, Rother RP, Matis LA, Elliott EA.

Transplantation. 1995 Dec 15;60(11):1299-306.

PMID:
8525525
43.

In vitro and in vivo inhibition of complement activity by a single-chain Fv fragment recognizing human C5.

Evans MJ, Rollins SA, Wolff DW, Rother RP, Norin AJ, Therrien DM, Grijalva GA, Mueller JP, Nye SH, Squinto SP, et al.

Mol Immunol. 1995 Nov;32(16):1183-95.

PMID:
8559143
44.

Purification of immunologically active recombinant 21.5 kDa isoform of human myelin basic protein.

Nye SH, Pelfrey CM, Burkwit JJ, Voskuhl RR, Lenardo MJ, Mueller JP.

Mol Immunol. 1995 Oct;32(14-15):1131-41.

PMID:
8544862
45.

Repair of plasmid and genomic DNA in a rad7 delta mutant of yeast.

Mueller JP, Smerdon MJ.

Nucleic Acids Res. 1995 Sep 11;23(17):3457-64.

46.

Amelioration of autoimmune reactions by antigen-induced apoptosis of T cells.

McFarland HI, Critchfield JM, Racke MK, Mueller JP, Nye SH, Boehme SA, Lenardo MJ.

Adv Exp Med Biol. 1995;383:157-66.

PMID:
8644500
47.

Mutations that relieve nutritional repression of the Bacillus subtilis dipeptide permease operon.

Slack FJ, Mueller JP, Sonenshein AL.

J Bacteriol. 1993 Aug;175(15):4605-14.

48.
50.

Identification of Bacillus subtilis adaptive response genes by subtractive differential hybridization.

Mueller JP, Mathiopoulos C, Slack FJ, Sonenshein AL.

Res Microbiol. 1991 Sep-Oct;142(7-8):805-13. Review.

PMID:
1784820

Supplemental Content

Loading ...
Support Center